Publicação
What are the Key Opportunities and Barriers for the Development, Adoption, and Scaling of Artificial Intelligence-based Second Opinion Platforms in the German Orthopedic sector? A case study of Doc Robin – comparative analysis of organisational expectations and external stakeholder perceptions
| Resumo: | This thesis analyzes the opportunities and barriers for the development, adoption, and scaling of AI-based Second Opinion platforms in German orthopedics, using DocRobin as a case study. Building on a mixed-methods approach, combining expert interviews, a patient survey, and business model analysis, the study examines technological, regulatory, economic, and stakeholder-related factors. The results reveal strong system-level efficiency and cost-saving potential, alongside significant challenges related to physician acceptance, dependencies and regulation. The findings provide strategic implications for digital health startups operating in highly regulated healthcare markets. |
|---|---|
| Autores principais: | Michalski, Jacob Maximilian |
| Assunto: | Innovation Digitalization AI Second-opinion Startup Healthcare Financing Value creation Expansion Digital transformation Technology Business model |
| Ano: | 2026 |
| País: | Portugal |
| Tipo de documento: | dissertação de mestrado |
| Tipo de acesso: | acesso aberto |
| Instituição associada: | Universidade Nova de Lisboa |
| Idioma: | inglês |
| Origem: | Repositório Institucional da UNL |
| Resumo: | This thesis analyzes the opportunities and barriers for the development, adoption, and scaling of AI-based Second Opinion platforms in German orthopedics, using DocRobin as a case study. Building on a mixed-methods approach, combining expert interviews, a patient survey, and business model analysis, the study examines technological, regulatory, economic, and stakeholder-related factors. The results reveal strong system-level efficiency and cost-saving potential, alongside significant challenges related to physician acceptance, dependencies and regulation. The findings provide strategic implications for digital health startups operating in highly regulated healthcare markets. |
|---|